A total of 3 large randomized trials (ie, the PLCO Cancer Screening Trial,15 the European Randomized Study of Screening for Prostate Cancer,25 and the Göteborg trial26) sought to determine whether organized PSA screening prevents PCa-specific mortality. The gene discussed is KLK3; the disease is cancer.